Article

Upregulation of TLR1, TLR2, TLR4, and IRAK-2 Expression During ML-1 Cell Differentiation…

ISRN Oncology · 2012 · Kassim Traore, author Barry Zirkin, author Rajesh K. Thimmulappa, author Shyam Biswal, author Michael A. Trush, author N. A. Franken, Academic Editor M. Loizidou, Academic Editor

Key facts

Title Upregulation of TLR1, TLR2, TLR4, and IRAK-2 Expression During ML-1 Cell Differentiation to Macrophages: Role in the Potentiation of Cellular Responses to LPS and LTA
First author Kassim Traore, author Barry Zirkin, author Rajesh K. Thimmulappa, author Shyam Biswal, author Michael A. Trush, author N. A. Franken, Academic Editor M. Loizidou, Academic Editor
Journal ISRN Oncology
Published Jan 6, 2012
DOI 10.5402/2012/641246
Devices mentioned K831519, K843085, K845013, K851606, K870482, K870488, K870489, K870494, K873092, K884572
Product codes mentioned JCJ, KIP, KIT

At a glance

  • 10–99 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature